↓ Skip to main content

Radiofrequency bipolar hemostatic sealer reduces blood loss, transfusion requirements, and cost for patients undergoing multilevel spinal fusion surgery: a case control study

Overview of attention for article published in Journal of Orthopaedic Surgery and Research, July 2014
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
37 Dimensions

Readers on

mendeley
52 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Radiofrequency bipolar hemostatic sealer reduces blood loss, transfusion requirements, and cost for patients undergoing multilevel spinal fusion surgery: a case control study
Published in
Journal of Orthopaedic Surgery and Research, July 2014
DOI 10.1186/s13018-014-0050-2
Pubmed ID
Authors

Steven M Frank, Jack O Wasey, Ian M Dwyer, Ziya L Gokaslan, Paul M Ness, Khaled M Kebaish

Abstract

BackgroundA relatively new method of electrocautery, the radiofrequency bipolar hemostatic sealer (RBHS), uses saline-cooled delivery of energy, which seals blood vessels rather than burning them. We assessed the benefits of RBHS as a blood conservation strategy in adult patients undergoing multilevel spinal fusion surgery.MethodsIn a retrospective cohort study, we compared blood utilization in 36 patients undergoing multilevel spinal fusion surgery with RBHS (Aquamantys®, Medtronic, Minneapolis, MN, USA) to that of a historical control group (n¿=¿38) matched for variables related to blood loss. Transfusion-related costs were calculated by two methods.ResultsPatient characteristics in the two groups were similar. Intraoperatively, blood loss was 55 % less in the RBHS group than in the control group (810¿±¿530 vs. 1,800¿±¿1,600 mL; p¿=¿0.002), and over the entire hospital stay, red cell utilization was 51 % less (2.4¿±¿3.4 vs. 4.9¿±¿4.5 units/patient; p¿=¿0.01) and plasma use was 56 % less (1.1¿±¿2.4 vs. 2.5¿±¿3.4 units/patient; p¿=¿0.03) in the RBHS group. Platelet use was 0.1¿±¿0.5 and 0.3¿±¿0.6 units/patient in the RBHS and control groups, respectively (p¿=¿0.07). The perioperative decrease in hemoglobin was less in the RBHS group than in the control group (¿2.0¿±¿2.2 vs. ¿3.2¿±¿2.1 g/dL; p¿=¿0.04), and hemoglobin at discharge was higher in the RBHS group (10.5¿±¿1.4 vs. 9.7¿±¿0.9 g/dL; p¿=¿0.04). The estimated transfusion-related cost savings were $745/case by acquisition cost and approximately 3- to 5-fold this amount by activity-based cost.ConclusionsThe use of RBHS in patients undergoing multilevel spine fusion surgery can conserve blood, promote higher hemoglobin levels, and reduce transfusion-related costs.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Italy 1 2%
Unknown 51 98%

Demographic breakdown

Readers by professional status Count As %
Other 6 12%
Researcher 6 12%
Student > Bachelor 5 10%
Student > Doctoral Student 5 10%
Student > Master 5 10%
Other 8 15%
Unknown 17 33%
Readers by discipline Count As %
Medicine and Dentistry 26 50%
Engineering 4 8%
Agricultural and Biological Sciences 2 4%
Nursing and Health Professions 2 4%
Neuroscience 1 2%
Other 1 2%
Unknown 16 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 July 2014.
All research outputs
#20,233,066
of 22,758,963 outputs
Outputs from Journal of Orthopaedic Surgery and Research
#1,165
of 1,364 outputs
Outputs of similar age
#191,851
of 227,324 outputs
Outputs of similar age from Journal of Orthopaedic Surgery and Research
#8
of 9 outputs
Altmetric has tracked 22,758,963 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,364 research outputs from this source. They receive a mean Attention Score of 3.4. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 227,324 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one.